# Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom

> **NCT01202253** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 50 (actual)

## Conditions studied

- Candidiasis

## Interventions

- **DRUG:** anidulafungin

## Key facts

- **NCT ID:** NCT01202253
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202253, "Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01202253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*